1,2,3-Tripalmitoleoyl glycerol is a triacylglycerol that contains palmitoleic acid (Item Nos. 10009871 | 21911) at the sn-1, sn-2, and sn-3 positions. It reduces red blood cell deformability in a concentration-dependent manner in a Reid''s filtration assay. Hepatic levels of 1,2,3-tripalmitoleoyl glycerol are increased in the JAK2L mouse model of hepatic steatosis. 1,2,3-Tripalmitoleoyl glycerol plasma levels are decreased in renal patients before dialysis.
1,2,3-Tripalmitoleoyl-rac-glycerol is a triacylglycerol containing palmitoleic acid at the sn-1, sn-2 and sn-3 positions. It reduces erythrocyte deformability in a concentration-dependent manner in the Reid filtration assay. Hepatic levels of 1,2,3-tripalmitoleoyl-rac-glycerol are increased in a JAK2L mouse model of hepatic steatosis. 1,2,3-Tripalmitoleoyl-rac-glycerol plasma levels are reduced in patients with predialysis renal disease.
ChEBI: 1,2,3-tripalmitoleoylglycerol is a triglyceride formed by acylation of the three hydroxy groups of glycerol with palmitoleic acid. It is functionally related to a palmitoleic acid.
Human Endogenous Metabolite
[1] C.Y. HONG . Effect of triacylglycerols on erythrocyte deformability in vitro[J]. Prostaglandins, leukotrienes, and essential fatty acids, 1993, 48 5: Pages 351-353. DOI:
10.1016/0952-3278(93)90114-c[2] CAMELLA G. WILSON. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.[J]. Endocrinology, 2016, 114 1: 570-585. DOI:
10.1210/en.2015-1866[3] DIANA M LEE. Oxidative stress and inflammation in renal patients and healthy subjects.[J]. PLoS ONE, 2011: e22360. DOI:
10.1371/journal.pone.0022360